|
overview
|
EXPERIENCE
Jefferson Medical College, Thomas Jefferson University
1992-1996: Professor of Pharmacology; Member, Jefferson Cancer Institute
1997-present: Professor of Microbiology & Immunology; Member, Kimmel Cancer Center; Member, Cardeza Foundation for Hematologic Research
2002-2005: Professor of Biochemistry & Molecular Pharmacology
2005-present: Professor of Biochemistry & Molecular Biology
2008-present: Adjunct Professor of Radiology, College of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
TEACHING EXPERIENCE (1992-present)
A. Thomas Jefferson University
Graduate: BI 515 General Biochemistry I; BI 612 Protein Function and Dysfunction; BI 614 Protein Structure and Function; BI 522 Experimental Principles in Molecular Biology; BI/PR 710,720,730 Biochemical/Pharmacological Literature Seminar; BT 411 Protein Purification and Characterization; GC 550 Foundations in Biomedical Sciences; GE 652 Molecular Basis of Cancer; PR 613 Structural Biology I; TE 521 Tissue Engineering
UNIVERSITY, COLLEGE, AND DEPARTMENTAL COMMITTEE SERVICE (1992-present)
Thomas Jefferson University
Strategic Planning Working Group on Cancer and Cancer Biology, 2005-2006
Clinical Cancer Research Review Committee, 1993-2009
Animal Resources Committee, 1997-8
Jefferson Medical College
Committee on Faculty Affairs, 2004-2009
Committee on Research, 2005-2008
Kimmel Cancer Center
2008-present: KCC Membership Committee
2008-present: KCC Prostate Cancer Working Group
2006-present: KCC Endocrine Mechanisms and Hormone Action in Cancer Program Committee
Seminar Committee, 2005-present
CD Facility Committee, 2000-2006
Development Therapeutics Committee, 1997-2006
NMR Facility Committee, 1993-2002
Computer Committee, 1993-7
Structural Biology Committee, 1993-7
Biochemistry and Molecular Biology
2007-present: Curriculum Committee (Chair, 2008-)
INVITED LECTURES (2008-present)
1. Genetic imaging. Center for Targeted Therapeutics and Translational Nanomedicine, University of Pennsylvania, Philadelphia, Pennsylvania, September 21, 2011.
2. Three dimensional projection environment for molecular design and surgical simulation. US Army Telemedicine & Advanced Technology Research Center Product Line Review, Frederick, Maryland, March 29, 2011.
3. Genetic imaging. Tinoco 80th Birthday Symposium, University of California, Berkeley, California, June 26, 2010.
4. Molecular Designs for Diagnosis and Therapy, Department of Bioengineering, University of California, Merced, April 13, 2009.
5. PET Imaging of Activated Cancer Gene mRNA in Tumors. New Frontiers of Science in Radiochemistry and Instrumentation for Radionuclide Imaging Workshop, Department of Energy, Bethesda, Maryland, November 5, 2008.
6. Multiple Radionuclide Nanoparticles for Genetic Imaging. New Frontiers of Science in Radiochemistry and Instrumentation for Radionuclide Imaging Workshop, Department of Energy, Bethesda, Maryland, November 5, 2008.
7. Scintigraphic imaging of KRAS mRNA in human pancreas cancer xenografts with ([111In]DO3A)n-poly(diamidopropanoyl)m-PNA-D(Cys-Ser-Lys-Cys) hybridization probes. Biophysical & Biomolecular Symposium: Targeted Delivery of Proteins and Nucleotides, American Chemical Society 236th Annual Meeting, Philadelphia, Pennsylvania, August 20, 2008.
8. Multicomponent molecular detection of breast cancer cells using nanotube electronic devices specific for cell surface receptors. Emerging Technologies: Nanobiotechnology, American Chemical Society 236th Annual Meeting, Philadelphia, Pennsylvania, August 20, 2008.
|